
Jorge Conde
General Partner
Jorge brings over two decades of experience in leading, building, and investing in the life sciences and healthcare sectors. He previously served as Chief Strategy Officer and Chief Product Officer at Syros Pharmaceuticals and co-founded Knome, a human genome interpretation company later acquired by Tute Genomics.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
Asia-Pacific
USA
Investment ranges
$500K - $1M
$1M - $3M
$3M - $10M
$10M - $50M
Focus areas
AI
Cybersecurity
Web3
Deeptech
Biotech
Health
Consumer
Fintech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.